Rujian Zhu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

CDK9 degrader induces BRCAness and sensitizes castration-resistant prostate cancer to PARP inhibitor.

CDK9 degrader induces BRCAness and sensitizes castration-resistant prostate cancer to PARP inhibitor.

Journal: Theranostics
Published: January 21, 2026

Real-World Study on the Impact of Novel Coronavirus Infection on Male Erectile Function.

Real-World Study on the Impact of Novel Coronavirus Infection on Male Erectile Function.

Journal: Clinical case reports
Published: January 05, 2025

SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3/CCL2/IL-6 axis and is regulated by VEZF1.

SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3/CCL2/IL-6 axis and is regulated by VEZF1.

Journal: Theranostics
Published: July 29, 2024

ZBP1 as a prognostic biomarker correlated with cell proliferation in clear cell renal cell carcinoma.

ZBP1 as a prognostic biomarker correlated with cell proliferation in clear cell renal cell carcinoma.

Journal: Heliyon
Published: May 19, 2024

FOXM1/KIF20A axis promotes clear cell renal cell carcinoma progression via regulating EMT signaling and affects immunotherapy response.

FOXM1/KIF20A axis promotes clear cell renal cell carcinoma progression via regulating EMT signaling and affects immunotherapy response.

Journal: Heliyon
Published: August 21, 2023

Giant peritoneal loose body and its protein composition: a case report.

Giant peritoneal loose body and its protein composition: a case report.

Journal: BMC urology
Published: July 22, 2023

CD44 Is a Prognostic Biomarker Correlated With Immune Infiltrates and Metastasis in Clear Cell Renal Cell Carcinoma.

CD44 Is a Prognostic Biomarker Correlated With Immune Infiltrates and Metastasis in Clear Cell Renal Cell Carcinoma.

Journal: Anticancer research
Published: June 02, 2023

Integrative analysis of the ST6GALNAC family identifies GATA2-upregulated ST6GALNAC5 as an adverse prognostic biomarker promoting prostate cancer cell invasion.

Integrative analysis of the ST6GALNAC family identifies GATA2-upregulated ST6GALNAC5 as an adverse prognostic biomarker promoting prostate cancer cell invasion.

Journal: Cancer cell international
Published: April 07, 2023

Antireflux Ureteral Stent Improves Stent-Related Symptoms and Quality of Life: A Prospective Randomized Controlled Trial.

Antireflux Ureteral Stent Improves Stent-Related Symptoms and Quality of Life: A Prospective Randomized Controlled Trial.

Journal: Journal of endourology
Published: March 11, 2023

Hsa_circ_0003596 enhances the development of cell renal clear cell carcinoma through the miR-502-5p/IGF1/PI3K/AKT axis.

Hsa_circ_0003596 enhances the development of cell renal clear cell carcinoma through the miR-502-5p/IGF1/PI3K/AKT axis.

Journal: The journal of gene medicine
Published: February 06, 2023

Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial.

Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial.

Journal: Chinese medical journal
Published: September 27, 2022

Identification of hexosamine biosynthesis pathway as a novel prognostic signature and its correlation with immune infiltration in bladder cancer.

Identification of hexosamine biosynthesis pathway as a novel prognostic signature and its correlation with immune infiltration in bladder cancer.

Journal: Frontiers in molecular biosciences
Published: August 01, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026